February 13, 2008 - Orqis Medical Corp’s MOMENTUM Trial Abstract was accepted for a late breaking clinical trial presentation at the upcoming American College of Cardiology (ACC) meeting, in which it will report on the hemodynamic and clinical effects of the percutaneous Cancion System in managing patients hospitalized with heart failure.
Barry Greenberg, M.D., director, Advanced Heart Failure Treatment Program, University of California San Diego Medical Center, and national principal investigator for the MOMENTUM Trial, will present, “Efficacy and Safety of Continuous Aortic Flow Augmentation in Patients Hospitalized with Acute Decompensated Heart Failure: Results of the MOMENTUM Trial,” Tuesday, April 1, 2008, from 1:45 pm to 2:00 pm, at the McCormick Place convention center, North Hall B1, in Chicago, IL.
For more information: www.orqis.com
April 06, 2026 
